Altered regulation of iron transport and storage in Parkinson's disease.
Parkinson's disease (PD) is characterized by the death of dopaminergic neurons in the substantia nigra. This neuronal degeneration is associated with a strong microglial activation and iron accumulation in the affected brain structures. The increased iron content may result from an increased iron penetration into the brain parenchyma due to a higher expression of lactoferrin and lactoferrin receptors at the level of the blood vessels and dopaminergic neurons in the substantia nigra in PD. Iron may also accumulate in microglial cells after phagocytosis of dopaminergic neurons. These effects may be reinforced by a lack of up-regulation of the iron storage protein ferritin, as suggested by an absence of change in iron regulatory protein 1 (IRP-1) control of ferritin mRNA translation in PD. Thus, a dysregulation of the labile iron pool may participate in the degenerative process affecting dopaminergic neurons in PD.
Hirsch
E C
EC
INSERM, UMR679, Experimental Neurology and Therapeutics, Hôpital de la Salpêtrière, Université Pierre & Marie Curie - Paris 6, Paris, France. hirsch@ccr.jussieu.fr
D000818:Animals; D006801:Humans; D017136:Ion Transport / Q000502:physiology; D007501:Iron / Q000378:metabolism*; D010300:Parkinson Disease / Q000378:metabolism* / Q000503:physiopathology*
D007501:Iron